ch.correia
TL2 · Turku
Contributes reviews on supplier material. Based in Turku.
Joined 14 July 2025 · last posted 3d
80 posts, newest first. Showing up to 150.
-
How shortages have affected compounding permissions Replied, post #67 · Access › Shortages · 25 Jul 2026 · 2 likes Shortages sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #91 · Access › Insurance & coverage · 23 Jul 2026 · 3 likes Since Prior authorisation keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
-
NHS criteria and how they are applied in practice Replied, post #27 · Regional › UK & Ireland · 12 Jul 2026 · 11 likes I had written a reply contradicting post #23 and deleted it. Here is what survived. Nothing in this subcategory is medical or legal advice, and prescribers reading here…
-
What is genuinely unknown about long-term amylin agonism Replied, post #17 · Compounds › Cagrilintide & amylin analogues · 9 Jul 2026 · 10 likes Nothing to add, except that this is the answer I would give if asked.
-
Micro-titration: a disputed topic, argued properly Replied, post #94 · Practice › Dosing & titration · 24 Jun 2026 · 25 likes Helpful, and short, which on this subject is harder than long.
-
Micronutrient adequacy at low total intake Replied, post #21 · Nutrition & Training › Protein & intake · 7 Jun 2026 · 0 likes Renal considerations around higher protein intake apply to people with existing renal impairment and are frequently generalised beyond that population. I have no…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #64 · Devices › Syringes & needles · 6 Jun 2026 · 32 likes This follows post #61 rather than contradicting it. Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub).…
-
How to disagree with an answer you were given, well Replied, post #6 · Start Here › How to Ask · 5 Jun 2026 · 14 likes This settles it for me, at least until somebody posts a reason it should not.
-
Injecting into an area that has become firm: why not to Replied, post #12 · Practice › Administration · 4 Jun 2026 · 1 like Answering the question post #8 raises rather than the one it answers. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #37 · Practice › Storage & stability · 4 Jun 2026 · 1 like Everything in post #35 holds. The case it does not cover is the one I have. Light protection is easy and cheap. The original carton exists for a reason and a vial…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #51 · Evidence › Journal club · 30 May 2026 · 3 likes The confident answers on SURMOUNT-1 and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
-
Micro-titration: a disputed topic, argued properly Replied, post #75 · Practice › Dosing & titration · 16 May 2026 · 20 likes Building on post #72 rather than restating it. I would rather this thread reach "we do not know" about micro-titration than reach a confident answer that nobody can…
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #18 · Evidence › Trials · 10 May 2026 · 3 likes Picking up post #17: that is the part I would want checked first. The figure that circulates in coverage is almost always whichever estimand gives the larger effect.…
-
Follow-up: How to disagree with an answer you were given, well Replied, post #2 · Start Here › How to Ask · 4 May 2026 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
A parcel stationary at a customs facility for nine days Replied, post #55 · Sourcing › Logistics · 3 May 2026 · 0 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #65 · Evidence › Trials · 29 Apr 2026 · 6 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #29 · Clinical › Bloodwork · 2 Apr 2026 · 0 likes Post #25 put the caveat in the right place and I want to underline it. Liver enzyme changes during rapid weight loss are commonly reported and have several possible…
-
Journal club: is percentage weight change the right endpoint? Replied, post #14 · Evidence › Journal club · 25 Mar 2026 · 0 likes Coming back to post #12, because the follow-up matters more than the original answer. Sessions on negative or null results are consistently the most instructive and the…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #62 · Practice › Storage & stability · 12 Mar 2026 · 17 likes Answering the question post #58 raises rather than the one it answers. Two sentences on Adsorptive losses and then I will stop, because the rest is speculation and the…
-
Second pass at: Identical chromatograms across two different lots Replied, post #54 · Sourcing › Red flags · 9 Mar 2026 · 17 likes The honest answer on Identical chromatograms is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #10 · Analytics › HPLC & UHPLC · 19 Feb 2026 · 0 likes Checked the Area percent versus weight percent claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting…
-
Designing a personal experiment that could change your mind — one year on Replied, post #9 · Research Methods › N-of-1 designs · 8 Feb 2026 · 0 likes Post #7 and I disagree about the size of the effect, not about the direction. Generalisability: a robust n-of-1 result applies to you. It does not tell you much about…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #119 · Analytics › COA interpretation · 27 Jan 2026 · 25 likes Good question, well framed, and I would like to see it answered properly.
-
The headache that turns out to be dehydration Replied, post #124 · Nutrition & Training › Hydration & electrolytes · 4 Jan 2026 · 25 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #34 · Outcomes › Body composition · 1 Jan 2026 · 30 likes DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is roughly ±1 kg for lean mass. Two scans six months apart on the same…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #30 · Clinical › Bloodwork · 1 Jan 2026 · 9 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Citation sweep results: how many references did not say what was claimed Replied, post #24 · Meta › Wiki maintenance · 30 Dec 2025 · 17 likes Post #22 put the caveat in the right place and I want to underline it. Distinguishing three things in the citation sweep results discussion that keep getting used…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #30 · Practice › Side effects · 27 Dec 2025 · 0 likes Answering the question post #29 raises rather than the one it answers. The published rates come from populations that were titrated on a defined schedule with clinical…
-
Dead volume across syringe and needle combinations Replied, post #43 · Devices › Syringes & needles · 24 Dec 2025 · 6 likes The quoted dead-volume figures for common configurations vary between manufacturers and the ordering is stable: fixed needle least, luer with hub more, luer with filter…
-
DXA precision and the least significant change for lean mass Replied, post #83 · Outcomes › Body composition · 19 Dec 2025 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Tirzepatide molecular mass and the charge states you would expect on ESI — does this… Replied, post #9 · Compounds › Tirzepatide · 18 Dec 2025 · 32 likes The published pharmacokinetics show dose proportionality across the studied range, which means dose arithmetic behaves the way you would naively expect. That is not…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #68 · Clinical › Special populations · 16 Dec 2025 · 2 likes Post #67 is right about the mechanism and I think understates the practical bit. Older adults were included in the trials in smaller numbers than their share of the…
-
Adolescents: a distinct evidence base — one year on Replied, post #43 · Clinical › Special populations · 13 Dec 2025 · 28 likes The most useful contribution here is usually a citation to whichever published document comes closest, with a plain statement of how far it is from the question.
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #8 · Access › International · 11 Dec 2025 · 12 likes Counterpoint on Language barriers in accessing, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the…
-
Second pass at: Programming during a large energy deficit Replied, post #46 · Nutrition & Training › Resistance training · 19 Oct 2025 · 0 likes A resistance stimulus during a deficit is the other half of the lean-tissue argument, and the evidence for it is reasonably strong. Small point, but it is the one that…
-
A comparison of home results against a laboratory result on the same vial Replied, post #51 · Analytics › Home & field testing · 19 Oct 2025 · 27 likes Research-use-only material is not certified for anything by anybody, and no home procedure changes that. What home checks buy you is early detection of the obvious…
-
A 40-week log with the measurement method stated Replied, post #33 · Outcomes › Progress reports · 19 Oct 2025 · 2 likes Worth separating two things that post #29 runs together. Answering the 40-week log question as asked, then the question I think is meant. As asked: yes, with the…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #71 · Sourcing › Vendor reports · 11 Oct 2025 · 0 likes Second this, and I would have said it less carefully.
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #67 · Start Here › How to Ask · 10 Oct 2025 · 1 like Say what you have already ruled out. "It is not the diluent because I tried a second vial from a different box" saves three replies suggesting the diluent. I have…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #42 · Evidence › Preprints · 29 Sep 2025 · 0 likes This follows post #41 rather than contradicting it. What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors…
-
Titles that describe the question, not the situation Replied, post #95 · Start Here › How to Ask · 13 Sep 2025 · 6 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Comparing my trajectory with the trial curves, carefully Replied, post #45 · Outcomes › Progress reports · 6 Sep 2025 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
A preprint whose numbers changed substantially at publication Replied, post #37 · Evidence › Preprints · 1 Sep 2025 · 6 likes Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry the same weight.
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #70 · Data & Tools › Calculators · 2 Aug 2025 · 14 likes Post #67 is right about the mechanism and I think understates the practical bit. The strongest argument against my own position on titration planner refuses, stated as…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #14 · Practice › Side effects · 2 Aug 2025 · 17 likes A note on how Fatigue gets discussed rather than on Fatigue itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have been…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #95 · Compounds › Tirzepatide · 27 Jul 2025 · 0 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #12 · Practice › Storage & stability · 23 Jul 2025 · 0 likes Helpful, and easy to find again, which is half of what a good reply is.
-
A field-by-field walk through a certificate of analysis Replied, post #94 · Analytics › COA interpretation · 17 Jul 2025 · 0 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
A supplier that answers analytical questions with restated claims Replied, post #118 · Sourcing › Red flags · 14 Jul 2025 · 5 likes Everything in post #116 holds. The case it does not cover is the one I have. I think the supplier question is answerable and has not been answered, which is a more…
-
Sequence verification for an obscure compound: how it is done Replied, post #85 · Compounds › Other compounds · 7 Jul 2025 · 1 like Research use only, not approved for human use, and in this subcategory the compounds vary enormously in how much is known about them. It is worth establishing which end…
-
Revisiting: Food effects on oral incretin absorption: what is documented Started this topic · Compounds › Oral incretins · 28 Jun 2025 · 55 likes Revisiting: Food effects on oral incretin absorption: what is documented — setting out what I have, and where I think it stops being reliable. Food effects on oral…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #74 · Compounds › Tirzepatide · 20 Jun 2025 · 0 likes Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly rather than through summarised claims. Reconstituted…
-
Titrating on tolerability rather than on the calendar Replied, post #2 · Practice › Dosing & titration · 19 Jun 2025 · 0 likes The most common practical error is not the schedule at all — it is losing track of which step you are on after a break, and then resuming at the top rather than…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #111 · Compounds › Cagrilintide & amylin analogues · 16 Jun 2025 · 7 likes I had written a reply contradicting post #109 and deleted it. Here is what survived. Research-use-only cagrilintide is not approved for human use and the published…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #95 · Compounds › Cagrilintide & amylin analogues · 14 Jun 2025 · 0 likes Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #50 · Devices › Pens & autoinjectors · 27 May 2025 · 1 like I came in to disagree and I am leaving without a disagreement.
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #18 · Analytics › Home & field testing · 22 May 2025 · 1 like Adding the measurement that post #16 says would settle it. Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues…
-
Dizziness on standing: the ordinary explanation first Replied, post #26 · Nutrition & Training › Hydration & electrolytes · 29 Apr 2025 · 19 likes Adding salt to food is the intervention most consistently reported as helping and is also the one least likely to cause harm.
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #65 · Practice › Interactions · 29 Apr 2025 · 22 likes Building on post #64 rather than restating it. Practical experience of delayed gastric emptying and oral, offered as one case with the conditions stated, not as a…
-
Asking about a compound your prescriber has not heard of Replied, post #24 · Clinical › Prescriber conversations · 25 Apr 2025 · 2 likes Confirming post #21 from a second method, which matters more than confirming it from a second person. Asking about the plan if the first approach does not work is a…
-
Reading a trial's population section before its results — does this still hold? Replied, post #12 · Evidence › Trials · 15 Apr 2025 · 23 likes This settles it for me, at least until somebody posts a reason it should not.
-
Second pass at: Pharmacy supply in the UK and the questions you will be asked Replied, post #28 · Regional › UK & Ireland · 7 Apr 2025 · 13 likes Post #25 answers the question as asked. The question underneath it is different. Waiting times are the most variable and least generalisable thing reported here, and…
-
Patterns that reliably precede a problem, documented Replied, post #8 · Sourcing › Red flags · 31 Mar 2025 · 14 likes Building on post #6 rather than restating it. Reporting rather than recommending, on patterns. What happened is above. Whether it should have is a different question…
-
Follow-up: Open-label extensions: what survives and what does not Replied, post #16 · Evidence › Trials · 22 Mar 2025 · 0 likes Everything in post #14 holds. The case it does not cover is the one I have. What I want from this Open-label extensions thread is the list of things that would need to…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #22 · Clinical › Bloodwork · 17 Jan 2025 · 27 likes Liver enzyme changes during rapid weight loss are commonly reported and have several possible explanations, which is exactly why they need clinical interpretation…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #10 · Compounds › Oral incretins · 25 Dec 2024 · 23 likes Where the Oral semaglutide bioavailability reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Building a sensible monitoring schedule with your prescriber Replied, post #67 · Clinical › Bloodwork · 21 Dec 2024 · 1 like The strongest argument against my own position on building a sensible monitoring schedule, stated as well as I can state it, since nobody else has yet.
-
Gallbladder disease risk with rapid weight loss Replied, post #42 · Clinical › Comorbidities · 11 Dec 2024 · 2 likes Post #38 put the caveat in the right place and I want to underline it. The claim about gallbladder disease risk upthread is stronger than its source supports. I have…
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #28 · Practice › Interactions · 1 Dec 2024 · 0 likes Oral contraceptive absorption has been studied specifically for some compounds in this class and the findings are compound-specific. Generalising from one to another is…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #28 · Compounds › Other compounds · 27 Nov 2024 · 0 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #45 · Compounds › Repair & healing peptides · 13 Nov 2024 · 17 likes Reading a preclinical wound-healing model would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #101 · Practice › Dosing & titration · 10 Nov 2024 · 0 likes Four-week escalation interval is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Signs of dehydration worth acting on Replied, post #35 · Safety › Adverse events · 26 Oct 2024 · 24 likes Post #34 is the version of this I will quote in future. One addition. Attribution is genuinely hard for a single case and the reporting schemes are designed to work…
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #71 · Clinical › Comorbidities · 21 Oct 2024 · 20 likes Hypertension improvement would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Reading a supplementary appendix and finding the interesting part Replied, post #8 · Evidence › Trials · 18 Oct 2024 · 0 likes This follows post #6 rather than contradicting it. I would be cautious about generalising from the reading a supplementary appendix example above. It is a good example.…
-
Requesting a page: what makes a good request — what changed since Replied, post #18 · Documentation › Wiki requests · 9 Oct 2024 · 9 likes Translation suggestions: if a maintained page should exist in another language, suggesting it here helps the maintainers prioritise multilingual work. That is all the…
-
Progressive overload when the scale is falling — one year on Replied, post #55 · Nutrition & Training › Resistance training · 14 Sep 2024 · 2 likes The arithmetic in post #54 is right; the assumption feeding it is the part to check. Two sentences on Progressive overload and then I will stop, because the rest is…
-
Reporting a discrepancy without making an allegation Replied, post #57 · Sourcing › Vendor reports · 4 Sep 2024 · 9 likes Two things can be true about reporting a discrepancy at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here…
-
Pen wastage and its effect on real cost Replied, post #16 · Access › Pricing · 16 Aug 2024 · 5 likes Cost per week at a maintenance dose is the figure most people actually want and least often calculate.
-
Blind submission and why it changes minds Replied, post #20 · Sourcing › Independent verification · 22 Jul 2024 · 0 likes Noted, and I have changed what I was going to do on the strength of it.